Recurrent primary hyperoxaluria type 2 leads to early post-transplant renal function loss: A case report
- PMID: 29545831
- PMCID: PMC5840950
- DOI: 10.3892/etm.2018.5841
Recurrent primary hyperoxaluria type 2 leads to early post-transplant renal function loss: A case report
Abstract
Primary hyperoxaluria type 2 is a rare autosomal recessive disorder caused by glyoxylate reductase/hydroxypyruvate reductase deficiency and characterized by recurrent episodes of nephrolithiasis and nephrocalcinosis. Herein, we describe a case of primary hyperoxaluria type 2 in a 33-year-old man who failed to respond to conventional therapies; thus renal transplantation was performed. This case demonstrated that, although primary hyperoxaluria type 2 is rare, hyperoxaluria should be suspected and blood oxalate and stone component be examined in patients with recurrent episodes of nephrolithiasis, particularly in those who are unresponsive to conventional therapies. Combined liver-kidney transplant may be required as kidney transplant alone is not likely to be successful.
Keywords: primary hyperoxaluria; renal calculus; renal transplant.
Figures
References
-
- Barratt TM, Danpure Hyperoxaluria CJ, Holliday MA, et al. Paediatric Nephrology. 3rd. Published Williams and Wilkins; Baltimore: 1994. pp. 557–572.
-
- Wuhl E, van Stralen KJ, Wanner C, Ariceta G, Heaf JG, Bjerre AK, Palsson R, Duneau G, Hoitsma AJ, Ravani P, et al. Renal replacement therapy for rare diseases affecting the kidney: An analysis of the ERA-EDTA registry. Nephrol Dial Transplant. 2014;29(Suppl 4):Siv1–Siv8. doi: 10.1093/ndt/gfu030. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources